The new oral adenosine A1 receptor agonist capadenoson in male patients with stable angina.

Trial Profile

The new oral adenosine A1 receptor agonist capadenoson in male patients with stable angina.

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Jul 2012

At a glance

  • Drugs Capadenoson (Primary)
  • Indications Angina pectoris
  • Focus Pharmacodynamics
  • Most Recent Events

    • 01 Jul 2012 Results published in Clinical Research in Cardiology.
    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top